IG ISOLO Trademark

Trademark Overview

On Wednesday, April 2, 2014, a trademark application was filed for IG ISOLO with the United States Patent and Trademark Office. The USPTO has given the IG ISOLO trademark a serial number of 86240194. The federal status of this trademark filing is PARTIAL SECTION 8 ACCEPTED as of Tuesday, October 3, 2023. This trademark is owned by CSL Behring AG. The IG ISOLO trademark is filed in the Education & Entertainment Services and Medical & Beauty Services & Agricultural Services categories with the following description:

[ Education and healthcare educational services, namely, providing training and programs concerning awareness and consequence of hemolysis, the risk of hemolysis occurring in certain patients receiving immunoglobulin infusion therapy and the identification and treatment with intravenous immunoglobulin therapy of patients in whom hemolysis may develop ]

Providing medical and pharmaceutical information to patients and healthcare practitioners, namely, providing medical information regarding hemolysis and the risk of occurrence in and the treatment of certain patients undergoing human intravenous immunoglobulin therapy and providing information relating to the therapeutic properties of pharmaceuticals for the treatment of hemolysis
ig isolo

General Information

Serial Number86240194
Word MarkIG ISOLO
Filing DateWednesday, April 2, 2014
Status704 - PARTIAL SECTION 8 ACCEPTED
Status DateTuesday, October 3, 2023
Registration Number5200229
Registration DateTuesday, May 9, 2017
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, October 7, 2014

Trademark Statements

Goods and Services[ Education and healthcare educational services, namely, providing training and programs concerning awareness and consequence of hemolysis, the risk of hemolysis occurring in certain patients receiving immunoglobulin infusion therapy and the identification and treatment with intravenous immunoglobulin therapy of patients in whom hemolysis may develop ]
Goods and ServicesProviding medical and pharmaceutical information to patients and healthcare practitioners, namely, providing medical information regarding hemolysis and the risk of occurrence in and the treatment of certain patients undergoing human intravenous immunoglobulin therapy and providing information relating to the therapeutic properties of pharmaceuticals for the treatment of hemolysis
Disclaimer with Predetermined Text"IG"

Classification Information

International Class041 - Education; providing of training; entertainment; sporting and cultural activities.
US Class Codes100, 101, 107
Class Status CodeB - Sec. 8 - Class(es) in a Multiple Class registration
Class Status DateTuesday, October 3, 2023
Primary Code041
First Use Anywhere DateSunday, July 31, 2016
First Use In Commerce DateSunday, July 31, 2016
International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateTuesday, April 15, 2014
Primary Code044
First Use Anywhere DateSunday, July 31, 2016
First Use In Commerce DateSunday, July 31, 2016

Trademark Owner History

Party NameCSL Behring AG
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressBern 22 CH-3000
CH
Party NameCSL Behring AG
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressBern 22, CH-3000
CH
Party NameCSL Behring AG
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressBern 22, CH-3000
CH

Trademark Events

Event DateEvent Description
Tuesday, October 3, 2023NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED
Tuesday, October 3, 2023REGISTERED - PARTIAL SEC. 8 (6-YR) ACCEPTED
Monday, October 2, 2023TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
Tuesday, September 19, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, September 19, 2023TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Tuesday, September 19, 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, September 19, 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, September 6, 2023POST REGISTRATION ACTION MAILED - SEC. 8
Wednesday, September 6, 2023CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Tuesday, April 11, 2023TEAS SECTION 8 RECEIVED
Monday, May 9, 2022COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Monday, December 17, 2018ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, December 17, 2018TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, May 9, 2017REGISTERED-PRINCIPAL REGISTER
Wednesday, April 5, 2017NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, April 4, 2017ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Tuesday, March 14, 2017STATEMENT OF USE PROCESSING COMPLETE
Monday, March 6, 2017USE AMENDMENT FILED
Monday, March 6, 2017TEAS STATEMENT OF USE RECEIVED
Wednesday, January 11, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, January 10, 2017SOU EXTENSION 4 GRANTED
Tuesday, November 29, 2016SOU EXTENSION 4 FILED
Friday, December 16, 2016RESPONSE TO ITU OFFICE ACTION ENTERED
Friday, December 16, 2016TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, December 13, 2016ITU OFFICE ACTION ISSUED FOR EXTENSION REQUEST
Tuesday, November 29, 2016SOU TEAS EXTENSION RECEIVED
Wednesday, July 6, 2016ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, July 6, 2016TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, April 28, 2016NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, April 27, 2016SOU EXTENSION 3 GRANTED
Tuesday, April 12, 2016SOU EXTENSION 3 FILED
Tuesday, April 12, 2016SOU TEAS EXTENSION RECEIVED
Thursday, December 3, 2015NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, December 2, 2015SOU EXTENSION 2 GRANTED
Friday, November 20, 2015SOU EXTENSION 2 FILED
Friday, November 20, 2015SOU TEAS EXTENSION RECEIVED
Friday, June 19, 2015NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, June 18, 2015SOU EXTENSION 1 GRANTED
Wednesday, May 20, 2015SOU EXTENSION 1 FILED
Thursday, June 18, 2015CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, May 20, 2015SOU TEAS EXTENSION RECEIVED
Tuesday, December 2, 2014NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, October 7, 2014OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, October 7, 2014PUBLISHED FOR OPPOSITION
Wednesday, September 17, 2014NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, September 2, 2014LAW OFFICE PUBLICATION REVIEW COMPLETED
Friday, August 29, 2014APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, August 29, 2014TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, August 29, 2014CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, August 26, 2014ASSIGNED TO LIE
Tuesday, August 26, 2014TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, May 22, 2014NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, May 22, 2014NON-FINAL ACTION E-MAILED
Thursday, May 22, 2014NON-FINAL ACTION WRITTEN
Friday, May 16, 2014ASSIGNED TO EXAMINER
Tuesday, April 15, 2014NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Saturday, April 5, 2014NEW APPLICATION ENTERED

Related Keywords

isolo hemolysis patients providing immunoglobulin information therapy treatment certain medical intravenous